Company / Revenue
Ceribell, Inc. Revenue History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$89.1M
FY2025
5-year range
$45.2M / $89.1M
FY2023-FY2025
Trend
+96.9%
vs FY2024
Sector context
#148 of 155
Health Care
What the data says
Among 155 Health Care companies, Ceribell, Inc. is in the bottom 5% for revenue. Improved from $45M to $89M over the past 2 years.
Based on SEC 10-K filings.
$89M in FY2025.
Improved from $45M to $89M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 155This company $89.1M Sector average $19.1B
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2025, revenue increased 96.9% year-over-year.
- Ranks #148 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $89.1M | +96.9% |
| FY2024 | $45.2M | +0.0% |
| FY2023 | $45.2M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026